Are peptides legal in Maine?

Can a Maine resident get peptides by telehealth?

Maine permits licensed physicians to treat patients through telehealth under rules adopted by the Board of Licensure in Medicine, which must hold telehealth care to the same standard as in-person care. Title 32, section 3300-D uses the definition of telehealth in Title 24-A, section 4316, which covers real-time interactive visits and asynchronous store-and-forward transfers. The same section limits physicians who are not licensed in Maine to registered, consultative interstate telehealth requested by a Maine-licensed physician, advanced practice registered nurse, or physician associate, who keeps authority over diagnosis and treatment. In practice, a telehealth clinic that prescribes directly to a Maine patient needs a prescriber with a full Maine license. Whether a prescription may be issued from an asynchronous (questionnaire or message-based) encounter alone is governed by the Board's telehealth rules and the standard of care rather than an express statute, so this record leaves it unconfirmed. None of the peptides in this database are controlled substances. [2] [3]

How does the Maine pharmacy board treat compounding?

The Maine Board of Pharmacy licenses pharmacists and pharmacies under the Maine Pharmacy Act, 32 M.R.S. chapter 117, and adopts practice rules in chapter 02-392 of the Code of Maine Rules. Section 13751, subsection 1, requires every pharmacy to obtain an annual Board license, and subsection 2 lists the classifications, including mail order prescription pharmacy. Board rules chapter 11, section 1 applies that classification to a pharmacy that dispenses prescription drugs by mail or carrier from a facility outside Maine to a patient who lives in Maine; the applicant must file a copy of its most recent inspection report from its home state and keep a toll-free line to a pharmacist open at least 40 hours a week. Inside Maine, a sterile compounding pharmacy needs a separate license under Board rules chapter 37, and non-sterile compounding must follow USP chapter 795 under Board rules chapter 13, section 7. A 2013 bill that would have required out-of-state pharmacies that compound drugs for Maine patients to hold their own annual Maine license (LD 1315, 126th Legislature) was vetoed, and the veto was sustained on June 26, 2013; section 13751 as checked on 2026-09-22 contains no compounding-specific license for out-of-state pharmacies, and the scope section of Board rules chapter 37 does not address pharmacies located outside Maine. Maine has no state bulks list; eligibility of a peptide for compounding follows the federal 503A framework (approved drug component, USP or NF monograph, or FDA 503A bulks list). [1] [4] [5] [6] [7] [8] [9] [10]

Can you get compounded GLP-1s in Maine?

Because Maine requires a pharmacy that mails prescriptions to Maine patients from outside the state to hold a mail order prescription pharmacy license, a telehealth GLP-1 program that ships a compounded vial into Maine from a pharmacy without that license is not lawful in the state. Maine patients should also confirm that the prescriber holds a full Maine license, since unregistered out-of-state physicians may only consult. [2] [5] [7] [13]

Prices by channel: semaglutide cost, tirzepatide cost.

Approvals, shortage history, and prices for every GLP-1 we track are on the GLP-1 hub.

What is the legal access path in Maine?

Find a provider in Maine

• Compounding pharmacies in Maine
• Clinics in Maine
• Telehealth providers in Maine

Is it legal to buy research peptides in Maine?

The Maine Pharmacy Act limits dispensing of prescription drugs to licensed pharmacies and practitioners, so an online seller of "research use only" injectable peptides to Maine consumers is not a lawful dispenser in Maine. [4] [14]

Peptide-specific notes for Maine

No peptide-specific rule identified for this jurisdiction. The general compounding and telehealth rules above apply, and the federal record covers semaglutide, tirzepatide, and BPC-157.

Frequently asked questions

Sources

Numbered citations above point to these primary sources: the state statute or rule, the pharmacy board, and federal FDA guidance.